| Product Code: ETC6770798 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Oncology NGS Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Oncology NGS Market - Industry Life Cycle |
3.4 Colombia Oncology NGS Market - Porter's Five Forces |
3.5 Colombia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Colombia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Colombia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Colombia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Colombia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Colombia Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Colombia |
4.2.2 Growing adoption of precision medicine in oncology treatment |
4.2.3 Rising demand for personalized and targeted therapies |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and services |
4.3.2 Limited reimbursement policies for NGS testing in Colombia |
4.3.3 Lack of awareness and understanding among healthcare professionals and patients about the benefits of NGS in oncology |
5 Colombia Oncology NGS Market Trends |
6 Colombia Oncology NGS Market, By Types |
6.1 Colombia Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Colombia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Colombia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Colombia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Colombia Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Colombia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Colombia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Colombia Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Colombia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Colombia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Colombia Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Colombia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Colombia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Colombia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Colombia Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Colombia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Colombia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Colombia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Colombia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Colombia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Colombia Oncology NGS Market Import-Export Trade Statistics |
7.1 Colombia Oncology NGS Market Export to Major Countries |
7.2 Colombia Oncology NGS Market Imports from Major Countries |
8 Colombia Oncology NGS Market Key Performance Indicators |
8.1 Number of oncology NGS tests performed annually in Colombia |
8.2 Adoption rate of NGS technology in oncology clinics and hospitals |
8.3 Percentage of oncologists trained in NGS techniques in Colombia |
9 Colombia Oncology NGS Market - Opportunity Assessment |
9.1 Colombia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Colombia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Colombia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Colombia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Colombia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Colombia Oncology NGS Market - Competitive Landscape |
10.1 Colombia Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Colombia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here